Comparative inhibitory effects of bepotastine and diphenhydramine on rituximab-induced infusion reactions
Sign Up to like & getrecommendations! Published in 2025 at "International Journal of Hematology"
DOI: 10.1007/s12185-025-03990-6
Abstract: Infusion-related reaction (IRR) is a common adverse event induced by rituximab. Although first-generation histamine 1 receptor antagonists (H1RAs) are commonly used to prevent IRR, evidence on IRR suppression by the second-generation H1RA bepotastine is scarce.… read more here.
Keywords: irr; rituximab induced; inhibitory effects; effects bepotastine ... See more keywords
Rituximab induced lung injury
Sign Up to like & getrecommendations! Published in 2025 at "BMC Pulmonary Medicine"
DOI: 10.1186/s12890-025-03802-x
Abstract: Rituximab is a chimeric human-mouse immunoglobulin monoclonal antibody with high affinity for CD20 surface antigens expressed by pre-B and B cells that is commonly used as the mainstay for the treatment of B cell non-Hodgkin’s… read more here.
Keywords: treatment; induced lung; rituximab induced; lung injury ... See more keywords
Rituximab-induced Acute Thrombocytopenia in Granulomatosis with Polyangiitis
Sign Up to like & getrecommendations! Published in 2018 at "Internal Medicine"
DOI: 10.2169/internalmedicine.0335-17
Abstract: A 72-year-old Japanese woman diagnosed with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis was admitted to our hospital with hearing loss, temporal pain, and sudden blindness. We finally diagnosed recurrent granulomatosis with polyangiitis and initiated methyl-prednisolone pulse… read more here.
Keywords: thrombocytopenia; granulomatosis polyangiitis; rituximab induced; acute thrombocytopenia ... See more keywords
Camptothecin enhances 131I-rituximab-induced G1-arrest and apoptosis in Burkitt lymphoma cells
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cancer Research and Therapeutics"
DOI: 10.4103/jcrt.jcrt_1012_19
Abstract: Background: Rituximab is a chimeric monoclonal antibody against CD20. It is an established immunotherapeutic agent for non-Hodgkin's lymphoma. Even though rituximab has been used in clinics for decades, only 50% of the patients respond to… read more here.
Keywords: rituximab; 131i rituximab; apoptosis; raji cells ... See more keywords